Wednesday, July 8, 2026

biotech · Breast Cancer · Advanced Breast Cancer · PBYI

PUMA BIOTECHNOLOGY

NovaPharmaNews editorial coverage mentioning PUMA BIOTECHNOLOGY — regulatory, clinical, and market analysis.

10880 Wilshire Blvd, Los Angeles, CA 90024, US HQ
2010 Founded
257 Employees
Public company Type
PBYI · NYSE Ticker
Company details
Status
Public
HQ
10880 Wilshire Blvd, Los Angeles, CA 90024, US
Founded
2010
Employees
257
Programs
40
Drugs
23
Patents
1
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning PUMA BIOTECHNOLOGY — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning PUMA BIOTECHNOLOGY — regulatory, clinical, and market analysis.

No coverage yet

We have not published news or analysis mentioning PUMA BIOTECHNOLOGY yet.

Back to company overview →